Zoomcar (ZCAR) 10-Q 10 Dec 21 2021 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Sep. 30, 2021	Dec. 10, 2021
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2021
Entity File Number	001-40964
Entity Registrant Name	INNOVATIVE INTERNATIONAL ACQUISITION CORP.
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1630742
Entity Address, Address Line One	24681 La Plaza Ste 300
Entity Address, City or Town	Dana Point
Entity Address State Or Province	CA
Entity Address, Postal Zip Code	92629
City Area Code	805
Local Phone Number	907-0597
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001854275
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false
Transition Report	false
Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Class A ordinary share, par value S0.0001 per share, and one-half of one redeemable warrant
Trading Symbol	IOACU
Security Exchange Name	NASDAQ
Class A Common Stock
Document Information [Line Items]
Title of 12(b) Security	Shares of Class A ordinary share, par value $0.0001 per share, included as part of the units
Trading Symbol	IOAC
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		24,060,000
Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
Document Information [Line Items]
Title of 12(b) Security	Redeemable warrants, each exercisable for one Class A ordinary share for $11.50 per share, included as part of the units
Trading Symbol	IOACW
Security Exchange Name	NASDAQ
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		8,050,000

UNAUDITED CONDENSED BALANCE SHE

UNAUDITED CONDENSED BALANCE SHEET	Sep. 30, 2021USD ($)
Assets
Deferred offering cost	$ 349,398
Total Assets	349,398
Current liabilities:
Accrued offering costs and expenses	260,368
Promissory note - related party	79,889
Total current liabilities	340,257
Commitments and Contingencies (Note 6)
Shareholder's Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	24,195
Accumulated deficit	(15,859)
Total shareholder's equity	9,141
Total Liabilities and Shareholder's Equity	349,398
Class A Common Stock
Shareholder's Equity:
Common stock	0
Class B Common Stock
Shareholder's Equity:
Common stock	$ 805

UNAUDITED CONDENSED BALANCE S_2

UNAUDITED CONDENSED BALANCE SHEET (Parenthetical) - USD ($)	Sep. 20, 2021	Sep. 30, 2021	Apr. 17, 2021	Mar. 31, 2021
Preferred stock, par value, (per share)		$ 0.0001		$ 0.0001
Preferred stock, shares authorized		1,000,000		1,000,000
Preferred stock, shares issued		0		0
Preferred stock, shares outstanding		0
Over-allotment option
Maximum shares subject to forfeiture		1,050,000
Sponsor
Amount paid to cover offering cost			$ 25,000
Sponsor | Founder Shares
Number of shares exchanged			7,187,500
Number of shares owned		8,050,000
Class A Common Stock
Common shares, par value, (per share)		$ 0.0001		$ 0.0001
Common shares, shares authorized		200,000,000		200,000,000
Common shares, shares issued		0
Common shares, shares outstanding		0
Class B Common Stock
Common shares, par value, (per share)		$ 0.0001		$ 0.0001
Common shares, shares authorized		20,000,000		20,000,000
Common shares, shares issued		8,050,000
Common shares, shares outstanding		8,050,000
Maximum shares subject to forfeiture		1,050,000
Common stock dividend per share		$ 1.12
Class B Common Stock | Sponsor | Founder Shares
Common shares, par value, (per share)			$ 0.0001
Maximum shares subject to forfeiture	1,050,000
Amount paid to cover offering cost			$ 25,000
Number of shares exchanged			7,187,500
Common stock dividend per share	$ 1.12
Number of shares owned	8,050,000

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	6 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS
Formation costs	$ 0	$ 15,859
Loss from operations	0	(15,859)
Net loss	$ 0	$ (15,859)
Weighted average shares outstanding, basic	7,000,000	7,000,000
Weighted average shares outstanding, diluted	7,000,000	7,000,000
Basic net loss per common share	$ 0	$ 0
Diluted net loss per common share	$ 0	$ 0

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)	Sep. 20, 2021	Sep. 30, 2021	Apr. 17, 2021
Sponsor
Amount paid to cover offering cost			$ 25,000
Sponsor | Founder Shares
Number of shares exchanged			7,187,500
Number of shares owned		8,050,000
Over-allotment option
Maximum shares subject to forfeiture		1,050,000
Class B Common Stock
Maximum shares subject to forfeiture		1,050,000
Common stock dividend per share		$ 1.12
Class B Common Stock | Sponsor | Founder Shares
Maximum shares subject to forfeiture	1,050,000
Amount paid to cover offering cost			$ 25,000
Number of shares exchanged			7,187,500
Common stock dividend per share	$ 1.12
Number of shares owned	8,050,000

UNAUDITED CONDENSED STATEMENT_3

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY - USD ($)	Class B Common StockCommon Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Mar. 21, 2021	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Mar. 21, 2021	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Class B ordinary shares issued to Sponsor	$ 805	24,195	0	25,000
Class B ordinary shares issued to Sponsor (in shares)	8,050,000
Net loss	$ 0	0	(15,859)	(15,859)
Balance at the end at Jun. 30, 2021	$ 805	24,195	(15,859)	9,141
Balance at the end (in shares) at Jun. 30, 2021	8,050,000
Balance at the beginning at Mar. 21, 2021	$ 0	0	0	0
Balance at the beginning (in shares) at Mar. 21, 2021	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(15,859)
Balance at the end at Sep. 30, 2021	$ 805	24,195	(15,859)	9,141
Balance at the end (in shares) at Sep. 30, 2021	8,050,000
Balance at the beginning at Jun. 30, 2021	$ 805	24,195	(15,859)	9,141
Balance at the beginning (in shares) at Jun. 30, 2021	8,050,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ 0	0	0	0
Balance at the end at Sep. 30, 2021	$ 805	$ 24,195	$ (15,859)	$ 9,141
Balance at the end (in shares) at Sep. 30, 2021	8,050,000

UNAUDITED CONDENSED STATEMENT_4

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDER'S EQUITY (Parenthetical) - USD ($)	Sep. 20, 2021	Sep. 30, 2021	Apr. 17, 2021
Sponsor
Amount paid to cover offering cost			$ 25,000
Sponsor | Founder Shares
Number of shares exchanged			7,187,500
Number of shares owned		8,050,000
Over-allotment option
Maximum shares subject to forfeiture		1,050,000
Class B Common Stock
Maximum shares subject to forfeiture		1,050,000
Common stock dividend per share		$ 1.12
Class B Common Stock | Sponsor | Founder Shares
Maximum shares subject to forfeiture	1,050,000
Amount paid to cover offering cost			$ 25,000
Number of shares exchanged			7,187,500
Common stock dividend per share	$ 1.12
Number of shares owned	8,050,000

UNAUDITED CONDENSED STATEMENT O

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS	6 Months Ended
	Sep. 30, 2021USD ($)
Cash flows from Operating Activities:
Net loss	$ (15,859)
Adjustments to reconcile net loss to net cash used in operating activities:
Formation costs paid by Sponsor	15,859
Net cash used in operating activities	0
Net change in cash	0
Cash, beginning of the period	0
Cash, end of the period	0
Supplemental disclosure of noncash investing and financing activities:
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	9,141
Deferred offering costs included in accrued offerings costs and expenses	79,889
Accrued expenses paid by Sponsor under the promissory note	$ 260,368

Organization, Business Operatio

Organization, Business Operation and Liquidity	6 Months Ended
	Sep. 30, 2021
Organization, Business Operation and Liquidity
Organization, Business Operation and Liquidity	Note 1 — Organization, Business Operation and Liquidity Innovative International Acquisition Corp. (the “Company”) was incorporated as a Cayman Islands exempted company on March 22, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses or entities (the “Business Combination”). The Company will not be limited to a particular industry or geographic region in its identification and acquisition of a target company. As of September 30, 2021, the Company had not commenced any operations. All activity for the period from March 22, 2021 (inception) through September 30, 2021, relates to the Company’s formation and the initial public offering described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering (as defined below). The Company has selected December 31 as its fiscal year end. The Company’s sponsor is Innovative International Sponsor I LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on October 26, 2021 (the “Effective Date”). On October 29, 2021, the Company consummated its IPO of 23,000,000 units (the “Units” and, with respect to the ordinary shares included in the Units being offered, the “Public Shares”) at $10.00 per Unit (which included the full exercise of the underwriters’ over-allotment option), which is discussed in Note 3 (the “Public Offering”) and the sale of 1,060,000 shares (the “Private Placement Shares”) at a price of $10.00 per Private Placement Share in a private placement to the Sponsor, and Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), and Cantor Fitzgerald & Co. (“Cantor”), the representative of the underwriters that closed simultaneously with the Public Offering, which is discussed in Note 4. Transaction costs amounted to $16,664,843 consisting of $3,173,059 of underwriting commissions, $12,100,000 of deferred underwriting commissions and $1,391,784 of other cash offering costs and were charged to equity. The initial Business Combination must occur with one or more operating businesses or assets with an aggregate fair market value equal to at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the signing a definitive agreement in connection with the initial Business Combination. However, the Company will only complete such Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully. Upon the closing of the Public Offering, management deposited an amount equal to at least $10.20 The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares (the “Public Shares”) upon the completion of the initial Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in the Company’s discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under the applicable law or stock exchange listing requirement. The shareholders will be entitled to redeem their shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two The ordinary shares subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation. In accordance with SEC and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require ordinary shares subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., public warrants), the initial carrying value of Class A ordinary shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The Class A ordinary shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to recognize the changes immediately. The accretion or remeasurement will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will have only 15 months from the closing of the Public Offering to complete the Business Combination (the “Combination Period”). If the Company is unable to consummate the Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses) divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the warrants, which will expire worthless if the Company fails to complete its initial Business Combination within the Combination Period. The Sponsor, officers, and directors have agreed (i) to waive their redemption rights with respect to their Founder Shares held by them, and any public shares they may acquire during or after the Public Offering in connection with the completion of the initial Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete its initial Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete its initial Business Combination within the prescribed time frame), and (iv) vote their Founder Shares and public shares in favor of the Company’s initial Business Combination. The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (i) $10.00 per public share or such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. Because we are a blank check company, rather than an operating company, and the Company’s operations will be limited to searching for prospective target businesses to acquire, the only third parties the Company currently expect to engage would be vendors such as lawyers, investment bankers, computer or information and technical services providers or prospective target businesses. Liquidity and Capital Resources As of September 30, 2021, the Company had no cash and a working capital deficit of $340,257. Following the consummation of the IPO on October 29, 2021, the Company had $2,800,472 of cash available to it, temporarily being held in the Sponsor’s bank account, and working capital of $1,210,696. The Company opened its operating bank account and the $2,800,472 was transferred to it from the Sponsor’s account on November 1, 2021. Prior to the completion of the Initial Public Offering, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statement. The Company has since completed its Initial Public Offering at which time capital in excess of the funds deposited in the Trust Account and/or used to fund offering expenses was released to the Company for general working capital purposes. Accordingly, management has since reevaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations one year from the date of this filing and therefore substantial doubt has been alleviated. Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the pandemic could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of this financial statement. The financial statement does not include any adjustments that might result from the outcome of this uncertainty.

Significant Accounting Policies

Significant Accounting Policies	6 Months Ended
	Sep. 30, 2021
Significant Accounting Policies
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus, which contains the initial audited financial statements and notes thereto for the period from March 22, 2021 (inception) to June 30, 2021, as filed with the SEC on October 28, 2021. The interim results for the three months ended September 30, 2021 and for the period from March 22, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future interim periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of this financial statement in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts. Offering Costs Associated with Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A—"Expenses of Offering”. Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are related to the Public Offering. Offering costs amounted to $16,664,843 and were charged to equity upon the completion of the IPO. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified in temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A common stock are affected by charges against additional paid in capital and accumulated deficit. As of September 30, 2021, there are no Class A ordinary shares subject to possible redemption outstanding. Warrants The Company accounts for its warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company accounts for the warrants as equity-classified. As such, the warrants were recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Net Loss Per Ordinary Share The Company applies the two-class method in calculating earnings per share. Net loss per ordinary share is computed by dividing the pro rata net loss between the redeemable ordinary shares and the non-redeemable ordinary shares of by the weighted average number of ordinary shares outstanding for each of the periods. The calculation of diluted loss per share does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. Income Taxes The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement. Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

Public Offering

Public Offering	6 Months Ended
	Sep. 30, 2021
Public Offering
Public Offering	Note 3 — Public Offering On October 29, 2021, the Company consummated its IPO of 23,000,000 Units, which included the full exercise of the underwriters’ over-allotment option, at a price of $10.00 per Unit, generating gross proceeds of $230,000,000. Each Unit consists of one Class A ordinary share and one

Private Placement

Private Placement	6 Months Ended
	Sep. 30, 2021
Private Placement.
Private Placement	Note 4 — Private Placement Simultaneously with the consummation of the IPO, the Sponsor, Cantor and CCM purchased an aggregate of 1,060,000 Class A ordinary shares (which included the full exercise of the underwriters’ over-allotment option), or Private Placement Shares, at a price of $10.00 per share ($10,600,000 in the aggregate) in a private placement that closed simultaneously with the closing of the offering. Of those 1,060,000 Private Placement Shares, the Sponsor purchased 960,000 shares, CCM purchased 30,000 shares and Cantor purchased 70,000 shares. The private placement shares will not be transferable, assignable or saleable until 30 days after the completion of the Initial Business Combination. Additionally, the Private Placement Shares will be non-redeemable so long as they are held by the Sponsor, CCM, Cantor or their permitted transferees. If the Private Placement Shares are held by holders other than the Sponsor, Cantor or their permitted transferees, the Private Placement Shares will be redeemable by the Company in all redemption scenarios.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Sep. 30, 2021
Related Party Transactions
Related Party Transactions	Note 5 — Related Party Transactions Founder Shares On April 17, 2021, the Sponsor paid $25,000 to cover certain offering costs in consideration for 7,187,500 Class B ordinary shares, par value $0.0001. On September 20, 2021, the Company effected a 1.12 share dividend for each Class B ordinary share outstanding, resulting in 8,050,000 Founder Shares being held by the Sponsor, up to 1,050,000 shares of which were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option was exercised. The underwriter fully exercised their over-allotment option on October 29, 2021 meant no Founder Shares were subject to forfeiture. All shares and related amounts have been retroactively restated to reflect the split. The Sponsor officers and directors have agreed not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (A) one year after the completion of the initial Business Combination or (B) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction after the initial Business Combination that results in all of the public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of our sponsor, officers and directors with respect to any Founder Shares (the “Lock-up”). Promissory Note — Related Party On April 17, 2021, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the Public Offering. These loans are non-interest bearing, unsecured and are due at the earlier of December 31, 2021, or the closing of the Public Offering. The loan will be repaid upon the closing of the Public Offering out of the offering proceeds not held in the Trust Account. As of September 30, 2021, the Company had $79,889 in borrowings under the promissory note. Working Capital Loans In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes its initial Business Combination, the Company would repay the Working Capital Loans. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of the Working Capital Loans may be convertible into warrants at a price of $1.50 per warrant, at the option of the lender. Such warrants would be identical to the Private Placement Shares. The terms of the Working Capital Loans by the Company’s officers and directors, if any, have not been determined and no written agreements exist with respect to the Working Capital Loans. The Company does not expect to seek loans from parties other than the Sponsor or an affiliate of the Sponsor as the Company does not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in the Company’s Trust Account. As of September 30, 2021, the Company had no borrowings under the Working Capital Loans. Office Space, Secretarial and Administrative Services The Company will reimburse the Sponsor for office space, secretarial and administrative services provided to members of the Company’s management team, in the amount of $10,000 per month. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.

Commitments & Contingencies

Commitments & Contingencies	6 Months Ended
	Sep. 30, 2021
Commitments & Contingencies
Commitments & Contingencies	Note 6 — Commitments & Contingencies Underwriters Agreement The Company granted the underwriters a 45-day option to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the Public Offering price less the underwriting discounts and commissions. The underwriters exercised the full over-allotment at the consummation of the Public Offering on October 29, 2021. The underwriters were entitled to a cash underwriting discount of two percent ( 2% ) of the gross proceeds of the Public Offering, or Additionally, the underwriters are entitled to five percent (5%) per unit (and seven percent (7%) per over-allotment unit, or $12,100,000 for deferred underwriting commissions. The deferred commissions will be payable only upon completion of the Business Combination. Financial Advisory Fee The Company engaged CCM, an affiliate of a passive member of the Company’s Sponsor, to provide consulting and advisory services in connection with the Public Offering, for which it received an advisory fee equal to 0.6% of the aggregate proceeds of this offering net of underwriter’s expenses. Affiliates of CCM have and manage investment vehicles with a passive investment in the Sponsor. CCM has agreed to defer the portion of its fee resulting from exercise of the underwriters’ over-allotment option until the consummation of the Company’s Business Combination. The Company will also engage CCM as an advisor in connection with the Company’s Business Combination for which it will earn an advisory fee of 1.05% of the proceeds of the Public Offering payable at closing of the Company’s Business Combination. CCM is engaged to represent the Company’s interests only. CCM is not participating in this offering as defined in FINRA Rule 5110(j)(16); it is acting as an independent financial adviser as defined in FINRA Rule 5110(j)(9). As such, CCM is not acting as an underwriter in connection with the Public Offering, it will not identify or solicit potential investors in this offering or otherwise be involved in the distribution of the Public Offering.

Shareholder's Equity

Shareholder's Equity	6 Months Ended
	Sep. 30, 2021
Shareholder's Equity
Shareholder's Equity	Note 7 — Shareholder’s Equity Preference shares outstanding Class A ordinary shares outstanding Class B ordinary shares outstanding Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided, however, that holders of the Class B ordinary shares will have the right to appoint all of the Company’s directors prior to the initial Business Combination and holders of the Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. These provisions of the Company’s amended and restated memorandum and articles of association may only be amended by a special resolution passed by at least 90% of the Founder Shares voting in a general meeting. Unless specified in the Companies Act, the Company’s amended and restated memorandum and articles of association or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders (other than the appointment of directors), and the affirmative vote of a majority of the Company’s Founder Shares is required to approve the appointment of directors. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination on a one-for-one basis, subject to adjustment for share subdivisions, share consolidations, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein and in the Company’s amended and restated memorandum and articles of association. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Public Offering and related to the closing of the initial Business Combination, the ratio at which Class B ordinary shares shall convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of all ordinary shares issued and outstanding upon completion of the Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination, and any Private Placement Shares issued to the Sponsor or its affiliates upon conversion of loans made to the Company). Any conversion of the Class B ordinary shares described herein will take effect as a compulsory redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one. Public Warrants and the Newly Issued Price, and the $18.00 per share redemption trigger price described adjacent to “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The warrants will become exercisable 30 days after the completion of the Company’s initial Business Combination and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file, and within 60 business days following the initial Business Combination to have declared effective, a registration statement covering the offer and sale of such shares and maintain a current prospectus relating to the Class A ordinary shares issuable upon exercise of the warrants, until the expiration of the warrants in accordance with the provisions of the warrant agreement. The Company cannot assure you that it will be able to do so if, for example, any facts or events arise which represent a fundamental change in the information set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not current or correct or the SEC issues a stop order. If the offer and sale of the shares issuable upon exercise of the warrants is not registered under the Securities Act, the Company will be required to permit holders to exercise their warrants on a cashless basis. However, no warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available. Notwithstanding the foregoing, if a registration statement covering the offer and sale of the Class A ordinary shares issuable upon exercise of the warrants is not effective within a specified period following the consummation of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of warrants. Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption (the “ 30-day redemption period”); and ● if, and only if, the last reported sale price (the “closing price”) of our Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant) for any 20 trading days within a 30- trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the warrant holder. ​

Subsequent Events

Subsequent Events	6 Months Ended
	Sep. 30, 2021
Subsequent Events
Subsequent Events	Note 8 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based on this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statement except as follows: On October 29, 2021 the Company consummated its IPO of 23,000,000 Units, which included the exercise in full of the underwriters’ option to purchase an additional 3,000,000 Units to cover over-allotments. Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share, and one Simultaneously with the closing of the IPO, the Company completed the private sale of an aggregate of 1,060,000 Class A Private Placement Shares to Innovative International Sponsor I LLC, Cantor Fitzgerald & Co. and J.V.B. Financial Group, LLC on behalf of its division, Cohen & Company Capital Markets at a purchase price of $10.00 per Private Placement Share, generating gross proceeds to the Company of $10,600,000. A total of $234,600,000 ($10.20 per Unit), comprised of $225,000,000 of the net proceeds from the IPO, including $12,100,000 of the underwriters’ deferred discount, and $9,600,000 of the proceeds of the sale of the Private Placement Shares, was placed in a U.S.-based trust account at Morgan Stanley Smith Barney LLC, maintained by American Stock Transfer & Trust Company, LLC, acting as trustee. An audited balance sheet as of October 29, 2021 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K. Additionally, CCM, an affiliate of a passive member of the Company’s Sponsor, provided consulting and advisory services in connection with the Public Offering, for which it received an advisory fee equal to 0.6% of the aggregate proceeds of this offering net of underwriter’s expenses (see Note 6). ​

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	6 Months Ended
	Sep. 30, 2021
Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with US GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s final prospectus, which contains the initial audited financial statements and notes thereto for the period from March 22, 2021 (inception) to June 30, 2021, as filed with the SEC on October 28, 2021. The interim results for the three months ended September 30, 2021 and for the period from March 22, 2021 (inception) through September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future interim periods.
Emerging Growth Company Status	Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non- emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of this financial statement in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with Initial Public Offering The Company complies with the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A—"Expenses of Offering”. Offering costs consist of legal, accounting, underwriting and other costs incurred through the balance sheet date that are related to the Public Offering. Offering costs amounted to $16,664,843 and were charged to equity upon the completion of the IPO.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified in temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A common stock are affected by charges against additional paid in capital and accumulated deficit. As of September 30, 2021, there are no Class A ordinary shares subject to possible redemption outstanding.
Warrants	Warrants The Company accounts for its warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. The Company accounts for the warrants as equity-classified. As such, the warrants were recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all of the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Net Loss Per Ordinary Share	Net Loss Per Ordinary Share The Company applies the two-class method in calculating earnings per share. Net loss per ordinary share is computed by dividing the pro rata net loss between the redeemable ordinary shares and the non-redeemable ordinary shares of by the weighted average number of ordinary shares outstanding for each of the periods. The calculation of diluted loss per share does not consider the effect of the warrants issued in connection with the IPO since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive.
Income Taxes	Income Taxes The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of September 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statement.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.

Organization, Business Operat_2

Organization, Business Operation and Liquidity (Details)	Nov. 01, 2021USD ($)	Oct. 29, 2021$ / sharesshares	Mar. 22, 2021	Sep. 30, 2021USD ($)$ / shares	Oct. 31, 2020$ / shares
Subsidiary, Sale of Stock [Line Items]
Condition for future business combination number of businesses minimum			1
Purchase price, per unit | $ / shares				$ 10.20
Transaction Costs				$ 16,664,843
Underwriting fees				3,173,059
Deferred underwriting fee payable				12,100,000
Other offering costs				$ 1,391,784
Condition for future business combination use of proceeds percentage				80
Condition for future business combination threshold Percentage Ownership				50
Maximum Allowed Dissolution Expenses				$ 100,000
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)				100.00%
Redemption of shares calculated based on business days prior to consummation of business combination (in days)				2 days
Condition for future business combination threshold Net Tangible Assets				$ 5,000,001
Months to complete acquisition				15 months
Redemption period upon closure				10 days
Cash				$ 0
Working Capital				$ 340,257
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares) | shares		23,000,000
Purchase price, per unit | $ / shares		$ 10		$ 10	$ 10.20
Months to complete acquisition				15 months
Private Placement
Subsidiary, Sale of Stock [Line Items]
Purchase price, per unit | $ / shares				$ 10
Private Placement | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) | shares		1,060,000
Sponsor
Subsidiary, Sale of Stock [Line Items]
Operating bank accounts	$ 2,800,472
Sponsor | Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Cash				$ 2,800,472
Working Capital				$ 1,210,696
Sponsor | Private Placement
Subsidiary, Sale of Stock [Line Items]
Price of warrant per share | $ / shares		$ 10

Significant Accounting Polici_3

Significant Accounting Policies - Additional Information (Details)	Sep. 30, 2021USD ($)shares
Cash equivalents	$ 0
Unrecognized tax benefits	0
Unrecognized tax benefits accrued for interest and penalties	0
Transaction Costs	16,664,843
Federal Depository Insurance Coverage	$ 250,000
Number Of Shares Subject To Forfeiture | shares	0

Public Offering (Details)

Public Offering (Details) - Initial Public Offering	Oct. 29, 2021USD ($)$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Number of units sold	23,000,000
Share Price | $ / shares	$ 10
Proceeds From Sale Of Units | $	$ 230,000,000
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit	1
Number of warrants in a unit	0.5
Number of shares issuable per warrant	1
Exercise price of warrants | $ / shares	$ 11.50

Private Placement (Details)

Private Placement (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2021	Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Shares issued price per share		$ 10.20
Aggregate purchase price	$ 25,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Shares issued price per share		$ 10
Aggregate purchase price		$ 10,600,000
Minimum period for transferable, assignable or saleable of shares		30 days
Private Placement | Sponsor
Subsidiary, Sale of Stock [Line Items]
Number of shares issued		960,000
Private Placement | CCM
Subsidiary, Sale of Stock [Line Items]
Number of shares issued		30,000
Private Placement | Cantor
Subsidiary, Sale of Stock [Line Items]
Number of shares issued		70,000
Private Placement | Class A Common Stock
Subsidiary, Sale of Stock [Line Items]
Number of shares issued		1,060,000

Related Party Transactions - Fo

Related Party Transactions - Founder Shares (Details) - USD ($)	Sep. 20, 2021	Apr. 17, 2021	Sep. 30, 2021
Class B Common Stock
Related Party Transaction [Line Items]
Common stock dividend per share			$ 1.12
Sponsor
Related Party Transaction [Line Items]
Amount paid to cover offering cost		$ 25,000
Founder Shares | Sponsor
Related Party Transaction [Line Items]
Restrictions on transfer period of time after business combination completion		1 year
Number of shares exchanged		7,187,500
Number of shares owned			8,050,000
Founder Shares | Sponsor | Class B Common Stock
Related Party Transaction [Line Items]
Amount paid to cover offering cost		$ 25,000
Number of shares exchanged		7,187,500
Common stock dividend per share	$ 1.12
Number of shares owned	8,050,000

Related Party Transactions - Pr

Related Party Transactions - Promissory Note - Related Party & Working Capital Loans (Details) - USD ($)	6 Months Ended
	Sep. 30, 2021	Apr. 17, 2021
Related Party Transaction [Line Items]
Working Capital	$ 340,257
Working capital loans warrant
Related Party Transaction [Line Items]
Borrowings under working capital loans	$ 0
Price of warrant per share	$ 1.50
Working Capital	$ 1,500,000
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note		$ 300,000
Repayment of promissory note - related party	79,889
Office Space Secretarial and Administrative Services
Related Party Transaction [Line Items]
Expenses per month	$ 10,000

Commitments & Contingencies (De

Commitments & Contingencies (Details) - USD ($)	Oct. 29, 2021	Sep. 30, 2021
Subsidiary, Sale of Stock [Line Items]
Cash underwriting discount rate		5.00%
Deferred underwriting fee payable		$ 12,100,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Number of units sold	23,000,000
Cash underwriting discount rate		2.00%
Underwriter cash discount		$ 4,000,000
Percentage of advisory fee		0.60%
Initial Public Offering | CCM
Subsidiary, Sale of Stock [Line Items]
Percentage of advisory fee		1.05%
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Underwriter option period		45 days
Cash underwriting discount rate		7.00%
Over-allotment option | Maximum
Subsidiary, Sale of Stock [Line Items]
Number of units sold		3,000,000

Shareholder's Equity - Preferen

Shareholder's Equity - Preference shares (Details) - $ / shares	Sep. 30, 2021	Mar. 31, 2021
Shareholder's Equity
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred stock, par value, (per share)	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0

Shareholder's Equity - Common S

Shareholder's Equity - Common Shares (Details)	6 Months Ended
	Sep. 30, 2021Vote$ / sharesshares	Oct. 29, 2021shares	Mar. 31, 2021$ / sharesshares
Class of Stock [Line Items]
Shares subject to forfeiture	0
Founder Shares
Class of Stock [Line Items]
Percentage of voting shares required in meeting	90.00%
Class A Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	200,000,000		200,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001		$ 0.0001
Common shares, shares issued (in shares)	0
Common shares, shares outstanding (in shares)	0
Class B Common Stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	20,000,000		20,000,000
Common shares, par value (in dollars per share) | $ / shares	$ 0.0001		$ 0.0001
Common shares, votes per share | Vote	1
Common shares, shares issued (in shares)	8,050,000
Common shares, shares outstanding (in shares)	8,050,000
Maximum shares subject to forfeiture	1,050,000
Percentage of shares issued and outstanding collectively own by initial shareholders	20.00%
Aggregated shares issued upon converted basis (in percent)	20.00%
Class B Common Stock | Founder Shares
Class of Stock [Line Items]
Shares subject to forfeiture		0

Shareholder's Equity - Public W

Shareholder's Equity - Public Warrants (Details) - Public Warrants	6 Months Ended
	Sep. 30, 2021D$ / sharesshares
Class of Warrant or Right [Line Items]
Public Warrants exercisable term	30 days
Public Warrants expiration term	5 years
Class A Common Stock
Class of Warrant or Right [Line Items]
Number of shares issuable per warrant | shares	1
Exercise price of warrants	$ 11.50
Threshold issue price per share	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%
Threshold trading days determining weighted average trading price	20 days
Maximum period after business combination in which to file registration statement	15 days
Period of time within which registration statement is expected to become effective	60 days
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)	180.00%
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Redemption period	30 days
Threshold trading days for redemption of public warrants	20 days
Threshold consecutive trading days for redemption of public warrants | D	30
Redemption Of Warrants When Price Per Share Of Class Common Stock Equals Or Exceeds 9.20
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 9.20
Adjustment one of redemption price of stock based on market value and newly issued price (as a percent)	115.00%

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Oct. 29, 2021	Jun. 30, 2021	Sep. 30, 2021	Mar. 31, 2021	Oct. 31, 2020
Subsequent Event [Line Items]
Aggregate purchase price		$ 25,000
Shares issued price per share			$ 10.20
Deferred underwriting fee payable			$ 12,100,000
Class A Common Stock
Subsequent Event [Line Items]
Common shares, par value (in dollars per share)			$ 0.0001	$ 0.0001
Class B Common Stock
Subsequent Event [Line Items]
Common shares, par value (in dollars per share)			$ 0.0001	$ 0.0001
Public Warrants | Class A Common Stock
Subsequent Event [Line Items]
Number of shares issuable per warrant			1
Exercise price of warrants			$ 11.50
Initial Public Offering
Subsequent Event [Line Items]
Number of units sold	23,000,000
Proceeds from sale of units	$ 230,000,000
Share Price	$ 10
Shares issued price per share	$ 10		$ 10		$ 10.20
Percentage of advisory fee			0.60%
Initial Public Offering | CCM
Subsequent Event [Line Items]
Percentage of advisory fee			1.05%
Initial Public Offering | Public Warrants
Subsequent Event [Line Items]
Number of shares in a unit	1
Number of warrants in a unit	0.5
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Private Placement
Subsequent Event [Line Items]
Aggregate purchase price			$ 10,600,000
Shares issued price per share			$ 10
Private Placement | CCM
Subsequent Event [Line Items]
Number of shares issued			30,000
Private Placement | Class A Common Stock
Subsequent Event [Line Items]
Number of shares issued			1,060,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Shares issued price per share	$ 10.20
Aggregate proceeds held in trust account	$ 234,600,000
Deferred underwriting fee payable	$ 12,100,000
Subsequent Event [Member] | Initial Public Offering
Subsequent Event [Line Items]
Number of units sold	23,000,000
Proceeds from sale of units	$ 230,000,000
Number of warrants in a unit	0.5
Exercise price of warrants	$ 11.50
Share Price	$ 10
Gross proceeds	$ 225,000,000
Subsequent Event [Member] | Initial Public Offering | CCM
Subsequent Event [Line Items]
Percentage of advisory fee	0.60%
Subsequent Event [Member] | Initial Public Offering | Class A Common Stock
Subsequent Event [Line Items]
Number of shares in a unit	1
Common shares, par value (in dollars per share)	$ 0.0001
Number of shares issuable per warrant	1
Subsequent Event [Member] | Over-allotment option
Subsequent Event [Line Items]
Number of units sold	3,000,000
Subsequent Event [Member] | Private Placement
Subsequent Event [Line Items]
Proceeds from sale of Private Placement Warrants	$ 9,600,000
Subsequent Event [Member] | Private Placement | Class A Common Stock
Subsequent Event [Line Items]
Aggregate purchase price	$ 10,600,000
Exercise price of warrants	$ 10
Number of shares issued	1,060,000